Medtronic Exploits Guidant’s Woes, Amassing Record 55% ICD Market Share
This article was originally published in The Gray Sheet
Executive Summary
Medtronic took advantage of Guidant's implantable cardioverter defibrillator recalls by capturing a record 55% of the U.S. market during its fiscal second quarter (ended Oct. 28)